BioTalk with Rich Bendis Podcast Dr. Laurie E. Locascio, Vice President for Research at both the University of Maryland College Park and Baltimore, Joins Rich Bendis on a New Episode of BioTalk Dr. Laurie E. Locascio, Vice President for Research at both the University of Maryland College…Super UserMay 28, 2021
News Dr. Laurie E. Locascio, Vice President for Research at both the University of Maryland College Park and Baltimore, Joins Rich Bendis on a New Episode of BioTalk Dr. Laurie E. Locascio, Vice President for Research at both the University of Maryland College…Super UserMay 28, 2021
News In Conversation: Montgomery County, Maryland Executive Marc Elrich · BioBuzz Montgomery County (MOCO), Maryland, sits at the epicenter of biopharma growth, investment, and innovation that…Super UserMay 26, 2021
News BioFactura Announces Initiation of Phase I Study of BFI-751, a Stelara® (ustekinumab) Biosimilar | Business Wire FREDERICK, Md.--(BUSINESS WIRE)--BioFactura, a leading developer of high-value biosimilar and biodefense drugs using its patented…Super UserMay 26, 2021
News NIH spinout raises millions to attack drug-resistant cancers with RNA. It has big plans. · BioBuzz A local biotech has secured millions of dollars in new investments to take its RNA therapies for…Super UserMay 26, 2021
News miRecule Inc. closes $5.7 M to Create Breakthrough RNA Therapies for Cancer and Muscular Dystrophy Gaithersburg, MD. (May ____ 2021) miRecule, Inc. (“miRecule”), an emerging biotech company focused on the…Super UserMay 25, 2021
News NIH spinout fighting cancer with RNA therapeutics raises millions – Washington Business Journal The startup is developing therapeutics for drug-resistant cancers — and applying its technology to other…Super UserMay 24, 2021
News Biohealth Innovation – SBIR Virtual Office Hours (BHI and MCEDC) (June 9) Are you and early stage company with innovative biohealth technology? Have you considered non-dilutive funding…Super UserMay 24, 2021
News Biohealth Innovation – SBIR Virtual Office Hours (BHI and MCEDC) (June 9) Are you and early stage company with innovative biohealth technology? Have you considered non-dilutive funding…Super UserMay 24, 2021
News RoosterBio Releases RoosterGEM™, Cell and Gene Therapy’s First Complete Transduction Medium RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cell (hMSC) working cell banks and…Super UserMay 24, 2021